Sign inJoin waitlistJoin the waitlist

Neal Edward Ready

Professor of Medicine · Duke Department of Medicine

Credentials: ·

History

Duke Department of Medicine
Present
Duke Cancer Institute
Present

Vanderbilt University School of Medicine
1986

Research

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2015 · 7,953 citations
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2015 · 7,024 citations
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · 2,096 citations

Scott Antonia
20 papers
Jeffrey Crawford
17 papers
Christopher Kelsey
16 papers
Thomas D'Amico
15 papers
Jeffrey Clarke
14 papers · 1 as a fellow
Lin Gu
13 papers · 7 as a resident
DS
David Spigel
12 papers
Everett Vokes
11 papers
Hossein Borghaei
11 papers
Julie Brahmer
10 papers
Junzo Chino
10 papers · 1 as a resident
HW
Harold Wanebo
9 papers

Clinical trials

TOP 2301: Neoadjuvant Chemo for NSCLC
Principal investigator · Suspended · Phase 2
Duke University
2025–2029
MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Principal investigator · Recruiting · Phase 1
Memgen, Inc.
2022–2031
Neoadjuvant Pembrolizumab
Principal investigator · Completed · Phase 2
Neal Ready MD PhD
2017–2024
Evaluation of Circulating T Cells and Tumor Infiltrating Lymphocytes (TILs) During / After Pre-Surgery Chemotherapy in Non-Small Cell Lung Cancer (NSCLC)
Principal investigator · Completed · Phase 2
Duke University
2013–2018